Nucleus

Nucleus Security Wins Risk-Based Vulnerability Management Award In 12th Annual Global InfoSec Awards

Retrieved on: 
Monday, May 6, 2024
Cloud, Risk management, Growth, FedRAMP, Triage, Organization, SAN, Nucleus, Risk

SAN FRANCISCO, May 6, 2024 /PRNewswire/ -- Nucleus Security , the leading innovator in enterprise risk-based vulnerability management, today announced it has been recognized with the Risk-Based Vulnerability Management award in Cyber Defense Magazine's 12th annual Global InfoSec Awards.

Key Points: 
  • SAN FRANCISCO, May 6, 2024 /PRNewswire/ -- Nucleus Security , the leading innovator in enterprise risk-based vulnerability management, today announced it has been recognized with the Risk-Based Vulnerability Management award in Cyber Defense Magazine's 12th annual Global InfoSec Awards.
  • Nucleus Security is a vulnerability and risk management platform that unifies existing tools in an organization's security infrastructure to establish a centralized command center for navigating the intricacies of vulnerability analysis, triage, and remediation.
  • "This recognition is a testament to the hard work and dedication of our team here at Nucleus," said Stephen Carter, co-founder and CEO of Nucleus Security.
  • The full list of Cyber Defense Magazine's Global InfoSec Award winners can be found here: http://www.cyberdefenseawards.com/

Forescout Research Elevates Warnings as Security Threats to Exposed Critical Infrastructure Go Ignored

Retrieved on: 
Tuesday, April 23, 2024
Software, Networks, Internet, Hardware, Utilities, Consumer Electronics, IOT (Internet of Things), Energy, Technology, Security, Homeland Security, Public Policy, Government, Research, OT, FTP, Modicon, Risk management, AEE, CISA, Good, Nucleus

After incidents targeting Modicon and Wago PLCs, Forescout researchers reexamined these exposed devices one year after reporting some to CISA.

Key Points: 
  • After incidents targeting Modicon and Wago PLCs, Forescout researchers reexamined these exposed devices one year after reporting some to CISA.
  • Forescout Research employs its Adversary Engagement Environment (AEE) to conduct analysis, leveraging a blend of real and simulated connected devices.
  • The AEE is maintained by Vedere Labs, a leading global team dedicated to uncovering vulnerabilities in and threats to critical infrastructure.
  • Forescout products directly leverage this research, which is shared openly with vendors, agencies, and other researchers.

For the Fourth Consecutive Year, UKG Ready Named a Leader in HCM for Leaner HR Teams

Retrieved on: 
Monday, April 22, 2024
Professional Services, Data Management, Technology, Human Resources, Software, Artificial Intelligence, Accounting, HR, Boba Tea Company, Organization, Workplace, Research, UKG, Nucleus, Life, Management

For the fourth consecutive year, UKG , a leading provider of HR, payroll, workforce management, and culture solutions for all people, today announced that UKG Ready is a Leader in the Nucleus Research SMB HCM Technology Value Matrix 2024.

Key Points: 
  • For the fourth consecutive year, UKG , a leading provider of HR, payroll, workforce management, and culture solutions for all people, today announced that UKG Ready is a Leader in the Nucleus Research SMB HCM Technology Value Matrix 2024.
  • UKG Ready empowers lean HR teams to build great workplace experiences through simple and intuitive technology that reduces complexity and empowers everyone.
  • “People leaders deserve a great technology experience no matter what size business they work for,” said Chris Kiklas, vice president of UKG Ready product management at UKG.
  • “UKG Ready, which is used by tens of thousands of businesses with lean HR teams, empowers great workplaces to keep it simple, so people leaders can focus on what matters most: their employees.”

UKG Named a Leader in HCM for Third Consecutive Year

Retrieved on: 
Tuesday, April 16, 2024
Data Management, Technology, IOT (Internet of Things), Professional Services, Other Technology, Software, Other Professional Services, Networks, Internet, Mobile, Wireless, Human Resources, Cloud, Organization, Magic Quadrant, Human resource management, AI, HR, Machine learning, Collection, Workplace, Research, Artificial intelligence, HCM, Forecasting, Culture, Trust, UKG, Nucleus, Management

For the third consecutive year, UKG Pro , the AI-powered HCM suite designed for larger organizations that prioritize cultures of trust and belonging, is a Leader in the Nucleus Research HCM Technology Value Matrix 2024 report.

Key Points: 
  • For the third consecutive year, UKG Pro , the AI-powered HCM suite designed for larger organizations that prioritize cultures of trust and belonging, is a Leader in the Nucleus Research HCM Technology Value Matrix 2024 report.
  • Each year, Nucleus Research assesses enterprise HCM vendors based on criteria including product usability, with UKG earning the highest positioning for both categories.
  • “I have never experienced an HCM solution with as much engagement power as UKG,” said Tina Barte, vice president of HR for Heartland Motor Company .
  • “UKG is a Leader for the third consecutive year because it continually leads the way in innovation to help businesses create great workplaces,” said Evelyn McMullen, research manager at Nucleus Research.

Lynn Bruder Acquires Nucleus Healthcare, Establishes Woman-Owned Healthcare Recruiting and Staffing Powerhouse

Retrieved on: 
Wednesday, April 10, 2024
Nursing, Government, American College, Patient, Bruder, Organization, Nucleus

PHILADELPHIA, April 10, 2024 /PRNewswire/ -- Nucleus Healthcare (Nucleus), a premier staffing and recruitment agency based in Philadelphia has become a woman-owned business.

Key Points: 
  • PHILADELPHIA, April 10, 2024 /PRNewswire/ -- Nucleus Healthcare (Nucleus), a premier staffing and recruitment agency based in Philadelphia has become a woman-owned business.
  • Current CEO, Lynn Bruder, acquired Nucleus through NuForce, LLC, dba Nucleus Healthcare.
  • Nucleus Healthcare, a staffing and recruitment agency based in PA has been acquired by the current CEO, Lynn Bruder.
  • "I am thrilled and honored to transform Nucleus Healthcare into one of the nation's most sought-after recruiting and staffing companies.

Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates

Retrieved on: 
Thursday, March 14, 2024
Nucleus, Bone marrow, BCMA, BioNTech, B-ALL, Patient, ALL, SLE, Engineering, Minocycline, European Medicines Agency, Therapy, Research, Canadian Aviation Regulations, Flow cytometry, ASH, General counsel, Immunotherapy, SVP, EMA, Legal Affairs, Trial of the century, GMP, SME, BLA, Nature Communications, Development, UCL, Biologics license application, Multiple myeloma, MIA, University College London, Senior, TRBC, GD2, ASCO, FDA, CD19, Conference call, Conference, MAA, EHA, ADS, MHRA, T cell, ACS Chemical Biology, PDUFA, Autoimmune disease, Pharmaceutical industry

“For now, we remain fully focused on preparing for a potential obe-cel launch and successfully transitioning Autolus to a commercial stage company.

Key Points: 
  • “For now, we remain fully focused on preparing for a potential obe-cel launch and successfully transitioning Autolus to a commercial stage company.
  • In February 2024, Autolus promoted Dr. Chris Williams to Chief Business Officer and Alex Driggs to Senior Vice President, Legal Affairs and General Counsel.
  • Dr. Leiderman brings extensive transactional and financial expertise, and Mr. Azelby brings more than 30 years of biopharmaceutical leadership and commercial experience to Autolus’ Board.
  • Financial Results for the Year Ended December 31, 2023

Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site

Retrieved on: 
Tuesday, March 12, 2024
Certification, Nucleus, Patient, Orphan, ALL, MIA, EMA, GMP, MHRA, Therapy, Priority, FDA, Pharmaceutical industry

This authorisation enables Autolus to manufacture for global commercial and clinical product supply from the Nucleus effective as of March 18, 2024.

Key Points: 
  • This authorisation enables Autolus to manufacture for global commercial and clinical product supply from the Nucleus effective as of March 18, 2024.
  • Following a full site inspection in February 2024, Autolus’s Nucleus site has recently received the formal certification from the MHRA.
  • The MHRA issued two new licenses to cover both clinical and commercial manufacture from the site and found no major or critical observations in their summary report.
  • Our manufacturing team did an outstanding job qualifying, validating and taking into operation the Nucleus in record time and establishing the foundation for high quality product supply,” commented Dave Brochu, Chief Technology Officer of Autolus.

Nucleus RadioPharma Announces Appointment of Chris McDonald from Kite, a Gilead Company, to Board of Directors

Retrieved on: 
Wednesday, March 27, 2024
Radiology, Pharmaceutical, Health, Oncology, Isotope, Growth, Kite, AstraZeneca, Nucleus, Novartis, Patient, Research, Cancer, Doctor of Philosophy, Radiopharmaceutical, Multimedia, Amgen, Medical imaging

Nucleus RadioPharma , the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Chris McDonald, Global Head of Technical Operations at Kite, a Gilead Company, to its Board of Directors.

Key Points: 
  • Nucleus RadioPharma , the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Chris McDonald, Global Head of Technical Operations at Kite, a Gilead Company, to its Board of Directors.
  • This addition underscores Nucleus RadioPharma's focus on operational excellence and its commitment to research and development, specifically tailored to the unique demands of the radiopharmaceutical sector.
  • View the full release here: https://www.businesswire.com/news/home/20240327530225/en/
    With the industry shifting towards isotopes that demand rapid production and distribution, McDonald's appointment is timely.
  • With Chris on board, we are poised to transform the radiopharmaceutical industry, making cancer treatments more accessible and saving the lives of patients with cancer.

Nucleus Genomics launches to bring whole-genome sequencing to the public

Retrieved on: 
Monday, March 25, 2024
Technology, Research, Medical Devices, Genetics, Biotechnology, Health, Pharmaceutical, Science, Consumer Electronics, Human Genome Project, WGS, Blood pressure, Genomics, Certification, Informatics, Genetic testing, Nucleus, Risk, Human, PRS, DNA, Accreditation, Breast, CAP, Overalls, Facial muscles, Cancer, CLIA, Breast cancer, BRCA2, BMI, BRCA1, Vaccine

Nucleus Genomics , the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.

Key Points: 
  • Nucleus Genomics , the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.
  • Nucleus will also offer pre-orders for its premium clinical-grade whole-genome sequencing (WGS) service, in which a customer’s entire set of DNA will be read and analyzed.
  • Nucleus is proud to sequence all customer samples in the U.S. on Illumina’s NovaSeq X Plus, the sequencing company’s newest and most innovative high-throughput sequencing instrument.
  • Working with Illumina, Nucleus is leveraging this latest sequencing technology to make WGS broadly accessible to power personalized healthcare.

Nucleus Research Releases 2024 Enterprise Human Capital Management Technology Value Matrix

Retrieved on: 
Tuesday, March 12, 2024
Professional Services, Business, Data Analytics, Technology, Software, Consulting, Artificial Intelligence, Research, SMB, Organization, Learning, Paylocity, Nucleus, Expert, Artificial intelligence, SAP, Acquisition, HCM, Infor, Machine learning, ADP, Risk management

This year, Nucleus has split the HCM Technology Value Matrix into two separate reports for SMB and enterprise-focused vendors.

Key Points: 
  • This year, Nucleus has split the HCM Technology Value Matrix into two separate reports for SMB and enterprise-focused vendors.
  • The Experts in this year’s Value Matrix are organizations that deliver value to customers with complex use cases through deep functionality and industry-specific capabilities.
  • Accelerators in this year’s Value Matrix deliver value through greater ease of use and quick implementation.
  • To download the full 2024 Enterprise HCM Technology Value Matrix, click here .